Home > Income Statement > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Revenue

    Back to Income Statement
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹218 Cr₹1,879 Cr₹159 Cr₹167 Cr₹127 Cr

What is the latest Revenue of JAGSONPAL PHARMACEUTICALS ?

The latest Revenue ratio of JAGSONPAL PHARMACEUTICALS is ₹218 Cr based on Mar2023 Standalone results.
Year Revenue
Mar2023₹218 Cr
Mar2022₹1,879 Cr
Mar2021₹159 Cr
Mar2020₹167 Cr
Mar2019₹127 Cr

How is Revenue of JAGSONPAL PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2023 ₹218 Cr
-88.42
Mar2022 ₹1,879 Cr
1,085.27
Mar2021 ₹159 Cr
-4.95
Mar2020 ₹167 Cr
31.84
Mar2019 ₹127 Cr -

Compare Revenue of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹944.9 Cr 3.6% 26.1% 6.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

3.6%

26.1%

6.4%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses